aiqbench analysis
This article focuses on Sarborg Limited, a firm leveraging quantum sampling to identify drug targets within complex biological networks that classical methods cannot efficiently solve. The piece details the company's significant capital raise, its specific intellectual property filings for disease modeling, and its strategic approach of running algorithms on existing classical infrastructure while preparing for future quantum hardware.
CDT Equity holds 22.7% stake in quantum firm Sarborg
CDT Equity Inc. holds 1,290 shares in Sarborg Limited, representing 22.7% of the issued share capital. Sarborg’s latest capital raise was at $125,000 per share, implying a fully diluted valuation of approximately $709 million.
CDT Equity now holds a 22.7 percent stake in Sarborg Limited, a quantum computing firm valued at approximately $709 million following its latest capital raise. Sarborg is applying quantum computation to the complex networks regulating disease genes to improve drug discovery, a challenge that exceeds the capabilities of conventional methods, the company says.…
Excerpt shown under the publisher's RSS terms · 53 words · full text and figures are on the publisher's site
Related coverage
Stock Market Today Highlights, Sept 2: Sensex ends 373 pts lower at 76, 570, Nifty below 24, 000; Asian Paints, HDFC Bank fall most
thehindubusinessline.com · Sep 2, 2026
Uncle Sam, shareholder: How the Trump administration became part owner of dozens of US companies - Las Vegas Sun News
lasvegassun.com · Sep 5, 2026
Rigetti Computing (NASDAQ: RGTI) Stock Price Down 4% Following Analyst Downgrade
themarketsdaily.com · Aug 21, 2026
D - Wave Quantum (NASDAQ: QBTS) Raised to Strong - Buy at BMO Capital Markets
tickerreport.com · Aug 22, 2026